Kalden Joachim R
Department of Internal Medicine III, Institute for Clinical Immunology, Erlangen, Germany.
J Rheumatol Suppl. 2002 Nov;66:27-37.
Biologic agents are an important addition to the therapeutic armamentarium for rheumatoid arthritis (RA). Initially these drugs were reserved for use in patients with progressive RA who had an inadequate response to treatment with disease modifying antirheumatic drugs. The optimal role of biologics in the treatment of RA remains to be defined. Data from ongoing clinical trials will provide insight on when to most effectively administer these agents.
生物制剂是类风湿性关节炎(RA)治疗手段的一项重要补充。最初,这些药物仅用于患有进行性RA且对改善病情抗风湿药物治疗反应不佳的患者。生物制剂在RA治疗中的最佳作用仍有待确定。正在进行的临床试验数据将为何时最有效地使用这些药物提供依据。